Clinical Responses to Rituximab in a Case of Neuroblastoma with Refractory Opsoclonus Myoclonus Ataxia Syndrome

Opsoclonus myoclonus ataxia syndrome (OMS) is a rare neurologic syndrome. In a high proportion of children, it is associated with neuroblastoma. The etiology of this condition is thought to be immune mediated. In children, immunotherapy with conventional treatments such as corticosteroids, intraveno...

Descripción completa

Detalles Bibliográficos
Autores principales: Alavi, Samin, Kord Valeshabad, Ali, Moradveisi, Borhan, Aminasnafi, Ali, Arzanian, Mohammad Taghi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502780/
https://www.ncbi.nlm.nih.gov/pubmed/23198199
http://dx.doi.org/10.1155/2012/164082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502780/
https://www.ncbi.nlm.nih.gov/pubmed/23198199
http://dx.doi.org/10.1155/2012/164082

Ejemplares similares